Breast cancer patients benefit from bone loss drug
Drug prevents bone loss for breast cancer patients
Posted: 10/10/2011
October is Breast Cancer Awareness Month. There is good news for women fighting bone-loss after treatment.
The bone density drug Zoledronic Acid is prescribed to fight Osteoporosis especially in post-menopausal women.
It has been given to breast cancer patients for the same reasons.
Now, in a new study published in the journal cancer, researchers say
the drug is doing its job.
Patients took the drug both at the start of their breast cancer therapy and others waited 36 months after starting treatment.
Taking the drug at the start protected against bone loss in the lower
spine and hip.
Copyright 2011 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
PRINT-
Think Pink with ABC2!
Think Pink this month with ABC2. Visit our Think Pink guide for information about this year's Komen Race.
Health
-
High stress with work-life balance
What is the most stressful part of your job? A new survey shows more people stress over their work-life balance than anything else at work.
-
Could c-sections lead to fatter babies?
Important news for expectant mothers, a new study finds babies born by c-section may be at higher risk for developing childhood obesity.
-
Healthy tips for Memorial Day cookouts
Here are some tips to make your Memorial Day cookout healthier.
